Soleus Capital Master Fund, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
TERN
Disclosed Ownership
212,710 shares
Ownership
0.2%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2026, 17:01:46 UTC
Date of event
31 Dec 2025
Previous filing
11 Feb 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP, LLC 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 0.2% 212,710 0 212,710 /s/ Guy Levy Guy Levy